Trials / Unknown
UnknownNCT02680769
Effect of Magnesium Supplementation in COPD
Daily Supplementation of Magnesium Citrate in Moderate-severe Chronic Obstructive Pulmonary Disease: a Randomized, Controlled, Double-blind Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (estimated)
- Sponsor
- University of Padova · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Magnesium (Mg) is involved in several pathways that could be affected in chronic obstructive pulmonary diseases (COPDs), namely in the contractility and excitability of neuro-muscolar endothelial cells and low-grade inflammation, a typical state of COPD. In this sense, several randomized controlled trials (RCTs) confirmed a positive role of Mg in asthma since long-period oral supplementation of Mg leads to a clinical and spirometric improvement. Subjects with COPD seem to have a reduced bioavailability of Mg probably due to the use of drugs that may increase Mg losses (e.g. beta-agonists and cortisones), to a reduced dietary Mg intake, and heavy smoking. A recent study showed that the administration of endovenous or aerosol Mg sulphate with beta-agonists acutely improve maximum expiratory flow during COPD relapses as well as the prolonged treatment with endovenous sulphate Mg led to a reduction in pulmonary hyperinflation and increase in muscles involved in respiration, with a consequent clinical and instrumental improvement. These evidences suggest that a chronic supplementation with Mg could improve COPD in clinical and instrumental parameters, but, at the best of our knowledge, no study was available in this sense.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 300 mg of citrate Mg | This group will take an oral supplementation of 300 mg of citrate magnesium |
| OTHER | Placebo | This group will take a placebo |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2018-03-01
- Completion
- 2019-03-01
- First posted
- 2016-02-12
- Last updated
- 2016-06-13
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02680769. Inclusion in this directory is not an endorsement.